Emasan AG, the investment arm of the Sandoz family, has sold a significant stake in Swiss pharmaceutical giant Novartis ...
(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group.
The Ferrari deal is expected to be the largest of a clutch of block trades this week, including a Sfr2.6bn (€2.8bn) block in ...
European stocks advanced to a record high as a slate of corporate earnings boosted sentiment, while investors monitored ...
17h
MT Newswires on MSNEuropean Equities Close Higher in Wednesday Trading; German Consumer Climate WanesThe European stock markets closed higher in Wednesday trading as The Stoxx Europe 600 rose 0.99%, Germany's DAX climbed 1.73%, the FTSE 100 in London gained 0.72%, France's CAC 40 advanced 1.15%, and ...
The Swiss army is set to spend CHF1.5 billion on new armaments. The 2025 Armed Forces Dispatch also plans to decommission the current Patrouille Suisse.
Montana, expressed his relief: “We can now proceed with this crucial work. We were rather worried, given the tight schedule.” Work is set to begin next week. The project includes renovating the timing ...
ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling ...
Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 ...
The Sandoz Family Foundation, Novartis's second-largest shareholder with a 4.1% stake, has announced plans to sell a substantial portion of its holdings in the pharmaceutical giant. This strategic ...
Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss ...
Country artist Paul Overstreet will headline the long list of talent slated to appear at the 15th Annual Cache Valley Cowboy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results